Dr.Wolfgang Willenbacher's second opinion

Dr. Wolfgang Willenbacher

Hematology, Oncology

Austria

32 years of experience

Choose for Consultation

Area of expertise

Specialty

Hematology, Oncology

Subspecialty

Hematologic Oncology

Diseases

Myeloma, Non-Hodgkin Lymphoma, AL Amyloidosis, Waldenstrom Macroglobulinemia, Follicular Lymphoma, Hodgkin Lymphoma, Hematologic Cancers

Procedures Performed

Autologous Stem-cell Transplantation

Chimeric Antigen Receptor T-cell Therapy

Immunochemotherapy

Experience

Associate Professor, Internal Medicine V, Medical University of Innsbruck

Innsbruck, Austria. From 2018

Senior Registrar, Internal Medicine V, Medical University of Innsbruck

Innsbruck, Austria. 2005 - 2018

Residency, Internal Medicine, Hospital Villingen-Schwenningen

Villingen-Schwenningen, Germany. 2001 - 2005

Residency, St. Josefs Hospital

Zell/Mosel, Germany. 2000 - 2001

Residency, Center for BMT-Oncology

Idar-Oberstein, Germany. 1998 - 2000

Residency, Tumorbiology Center

Freiburg, Germany. 1995 - 1998

Internship, Tumorbiology Center

Freiburg, Germany. 1993 - 1994

Education

MD, Medical Faculty in Heidelberg

1995

Biography

Dr. Wolfgang Willenbacher is a hematologist with a specialization in Lymphoma & Myeloma. He is an Associate Professor of Internal Medicine V at the Medical University of Innsbruck in Austria, a position he has held since 2018. He has a vast amount of work experience, including serving as a Senior Registrar in Internal Medicine V at the Medical University of Innsbruck for 13 years, from 2005 to 2018. Prior to that, he held various residency positions, including at the Hospital Villingen-Schwe...nningen in Germany, the St. Josefs Hospital in Zell/Mosel, Germany, the Center for BMT-Oncology in Idar-Oberstein, Germany, and the Tumorbiology Center in Freiburg, Germany. He also completed an internship at the Tumorbiology Center in Freiburg, Germany. Dr. Willenbacher received his MD from the Medical Faculty in Heidelberg in 1995. He has additional training in Internal Medicine, Emergency Medicine, Hematology & Oncology, and Clinical Trial Management. Dr. Willenbacher has participated in over 25 clinical trials in the field of hematology and oncology and has published more than 70 papers. His research areas are Blood Disorders & Transfusion, and he performs ASCT, CAR-T, and Immuno-Chemotherapy.

You’re only one click away from a life-changing journey

Virtual health assistant powered by AI
350+ world-renowned Doctors